
A Roadmap for Introducing Novel Excipients: How to Approach Excipient Qualification with the FDA
One of the most common formulation issues that sponsors of new drug or biologic products face is the qualification of novel excipients. Although novel excipients can be a part of any new drug application (NDA) or biologics license application (BLA) development program, they seem to